Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cutera, Inc.

< Previous 1 2 Next >
FDA Clears AviClear® as a Long-Term Treatment for Mild to Severe Acne
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera® Celebrates One Year of Revolutionizing the Acne Market with AviClear® During Acne Awareness Month
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Cancels Special Meeting
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Comments on Termination of Voce Capital’s Special Meeting Proxy Solicitation
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Announces Agreements with Pura Vida and RTW
From CUTERA, INC.
Via Business Wire
Tickers CUTR
Cutera Announces First Quarter 2023 Financial Results
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Announce First Quarter Results on May 9, 2023
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc.’s Special Committee Updates Stockholders on Its Recent Steps to Protect Stockholder Interests
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera® Celebrates 25 Years of Excellence in Innovation
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Hold Special Meeting of Stockholders
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Announces Executive Leadership and Governance Changes
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Regains Compliance with Nasdaq Listing Rules
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Acknowledges Receipt of Special Meeting Demand from Daniel Plants
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-K
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera® Unveils the Reimagined truBody® Brand
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Announces Fourth Quarter and Full-Year 2022 Financial Results along with 2023 Outlook
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2022 Results on February 28, 2023
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2022
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Announces Pricing of Offering of $100 Million of Convertible Senior Notes
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Announces Proposed Private Offering of $100 Million of Convertible Senior Notes
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. Provides Response to FDA Inquiry
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Participate in a Fireside Chat at the Stifel Healthcare 2022 Conference
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference
From Cutera, Inc.
Via Business Wire
Tickers CUTR
AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Announces Third Quarter 2022 Financial Results
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera’s AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology Conference
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera, Inc. to Announce Third Quarter Results on November 3, 2022
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Announces Over 1,000 AviClear™ Acne Treatments Performed
From Cutera, Inc.
Via Business Wire
Tickers CUTR
Cutera Announces Second Quarter 2022 Financial Results
From Cutera, Inc.
Via Business Wire
Tickers CUTR
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.